484 related articles for article (PubMed ID: 9258096)
1. Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer.
Brennemann W; Stoffel-Wagner B; Helmers A; Mezger J; Jäger N; Klingmüller D
J Urol; 1997 Sep; 158(3 Pt 1):844-50. PubMed ID: 9258096
[TBL] [Abstract][Full Text] [Related]
2. Gonadal function after multimodality treatment in men with testicular germ cell cancer.
Palmieri G; Lotrecchiano G; Ricci G; Spiezia R; Lombardi G; Bianco AR; Torino G
Eur J Endocrinol; 1996 Apr; 134(4):431-6. PubMed ID: 8640293
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment follicle-stimulating hormone: a prognostic serum marker of spermatogenesis status in patients treated for germ cell cancer.
Brennemann W; Stoffel-Wagner B; Wichers M; Helmers A; Albers P; Mezger J; Klingmüller D
J Urol; 1998 Jun; 159(6):1942-6. PubMed ID: 9598493
[TBL] [Abstract][Full Text] [Related]
4. The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumors.
Gerl A; Mühlbayer D; Hansmann G; Mraz W; Hiddemann W
Cancer; 2001 Apr; 91(7):1297-303. PubMed ID: 11283930
[TBL] [Abstract][Full Text] [Related]
5. Reproductive toxicity with and without LHRHA administration during adjuvant chemotherapy in patients with germ cell tumors.
Kreuser ED; Hetzel WD; Hautmann R; Pfeiffer EF
Horm Metab Res; 1990 Sep; 22(9):494-8. PubMed ID: 1701752
[TBL] [Abstract][Full Text] [Related]
6. Long-term fertility and Leydig cell function in patients treated for germ cell cancer with cisplatin, vinblastine, and bleomycin versus surveillance.
Hansen SW; Berthelsen JG; von der Maase H
J Clin Oncol; 1990 Oct; 8(10):1695-8. PubMed ID: 1698935
[TBL] [Abstract][Full Text] [Related]
7. Testicular function in patients with testicular cancer treated with bleomycin-etoposide-carboplatin (BEC(90)) combination chemotherapy.
Pectasides D; Pectasides M; Farmakis D; Nikolaou M; Koumpou M; Kostopoulou V; Mylonakis N
Eur Urol; 2004 Feb; 45(2):187-93. PubMed ID: 14734005
[TBL] [Abstract][Full Text] [Related]
8. Testicular function in poor-risk nonseminomatous germ cell tumors treated with methotrexate, paclitaxel, ifosfamide, and cisplatin combination chemotherapy.
Pectasides D; Pectasides E; Papaxoinis G; Skondra M; Gerostathou M; Karageorgopoulou S; Kamposioras C; Tountas N; Koumarianou A; Psyrri A; Macheras A; Economopoulos T
J Androl; 2009; 30(3):280-6. PubMed ID: 19136393
[TBL] [Abstract][Full Text] [Related]
9. Endocrinological late effects after chemotherapy for testicular cancer.
Berger CC; Bokemeyer C; Schuppert F; Schmoll HJ
Br J Cancer; 1996 May; 73(9):1108-14. PubMed ID: 8624272
[TBL] [Abstract][Full Text] [Related]
10. Pituitary and testicular hormonal function after treatment for germ cell tumours.
Bosl GJ; Bajorunas D
Int J Androl; 1987 Feb; 10(1):381-4. PubMed ID: 2438229
[TBL] [Abstract][Full Text] [Related]
11. Testicular function in patients with testicular cancer treated with orchiectomy alone or orchiectomy plus cisplatin-based chemotherapy.
Hansen PV; Trykker H; Helkjoer PE; Andersen J
J Natl Cancer Inst; 1989 Aug; 81(16):1246-50. PubMed ID: 2474077
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal Changes in Serum Levels of Testosterone and Luteinizing Hormone in Testicular Cancer Patients after Orchiectomy Alone or Bleomycin, Etoposide, and Cisplatin.
Bandak M; Jørgensen N; Juul A; Lauritsen J; Kier MGG; Mortensen MS; Daugaard G
Eur Urol Focus; 2018 Jul; 4(4):591-598. PubMed ID: 28753832
[TBL] [Abstract][Full Text] [Related]
13. Semen quality and reproductive hormones before orchiectomy in men with testicular cancer.
Petersen PM; Skakkebaek NE; Vistisen K; Rørth M; Giwercman A
J Clin Oncol; 1999 Mar; 17(3):941-7. PubMed ID: 10071288
[TBL] [Abstract][Full Text] [Related]
14. Gonadal function in patients with testicular germ cell tumors.
Tomomasa H; Oshio S; Ashizawa Y; Kamiyama Y; Okano Y; Iiyama T; Sato S; Shimizu H; Umeda T
Arch Androl; 2002; 48(6):405-15. PubMed ID: 12425758
[TBL] [Abstract][Full Text] [Related]
15. Fertility after chemotherapy for testicular cancer.
Drasga RE; Einhorn LH; Williams SD; Patel DN; Stevens EE
J Clin Oncol; 1983 Mar; 1(3):179-83. PubMed ID: 6199473
[TBL] [Abstract][Full Text] [Related]
16. Fertility after high-dose chemotherapy for testicular cancer.
Ishikawa T; Kamidono S; Fujisawa M
Urology; 2004 Jan; 63(1):137-40. PubMed ID: 14751366
[TBL] [Abstract][Full Text] [Related]
17. Gonadal function after surgery and chemotherapy in men with stage II and III nonseminomatous testicular tumors.
Nijman JM; Schraffordt Koops H; Kremer J; Sleijfer DT
J Clin Oncol; 1987 Apr; 5(4):651-6. PubMed ID: 3104546
[TBL] [Abstract][Full Text] [Related]
18. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
[TBL] [Abstract][Full Text] [Related]
19. Serum gonadotropin levels in patients with germ-cell tumors of the testis: interrelations, possible cross-reactions and interpretation of beta-HCG level.
Kovcin VN; Jelić SB; Ivanović SM; Babović NL
Int J Biol Markers; 1997; 12(2):55-60. PubMed ID: 9342633
[TBL] [Abstract][Full Text] [Related]
20. Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy.
Brydøy M; Fosså SD; Klepp O; Bremnes RM; Wist EA; Wentzel-Larsen T; Dahl O;
Eur Urol; 2010 Jul; 58(1):134-40. PubMed ID: 20395037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]